Elsevier Brings Latest Book Title, ChemApps: _Strategic Applications of Named Reactions in Organic Synthesis (SANROS)_ to the App Store
Waltham, MA, April 26, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the release of ChemApps: Strategic Applications of Named Reactions in Organic Synthesis (SANROS), the second in a new series of apps for iPhone, iPod touch, or iPad based on Elsevier books. The first title, NeuroApps: MRI Atlas of Human White Matter, is also available on the App Store.
Created from the best-selling Strategic Applications of Named Reactions in Organic Synthesis by László Kürti and Barbara Czakó, ChemApps: SANROS provides organic chemists with time-saving information about chemical reactions from a trusted source, along with unique search and filter functions.
“We’re honored to adapt Kürti’s and Czakó’s indispensable print reference for the iPhone and iPod touch,” ... .
ChemApps: SANROS, available exclusively on the App Store, enables professional organic chemists to search and examine the chemical transformations extracted from the book using new interactive features:
- The ability to search and filter 250 reactions by type, category, name and functional group, enables users to find a reaction from a number of different starting points.
- Each reaction page includes an overview, which includes a summary of the particular transformation the reaction performs; the mechanism, which reveals how the reaction works; applications, showing how the reaction is used in practice; and references for further reading.
- A list of over 450 chemical abbreviations, showing the full name and structure (where relevant).
- A handy bookmark feature that allows users to save a reaction for quick retrieval.
[snip]
The ChemApps: SANROS App is available for $9.99 from the App Store on iPhone and iPod touch or at www.itunes.com/appstore. A free version, featuring 25 named reactions, is also available to download.
Source and Links to Apps, Fulltext and Video Trailer Available At
[http://bit.ly/IbElvE]
No comments: